Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AJUAR: Ajmaline for Arrhythmias and Brugada Diagnosis
NCT00702117Phase 4Completed
- Sponsor
- Hospital Clínic de Barcelona
- Start
- Jun 2008
- Primary completion
- Jan 2010
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of ajmaline in Atrial fibrillation (AFib), ventricular tachycardia (VT), sponsored by Hospital Clínic de Barcelona. Started Jun 2008; status: completed.
02
Drugs
ajmaline
03
Conditions
Atrial fibrillation (AFib)ventricular tachycardia (VT)
Beyond the preview
Go deeper on NCT00702117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00702117.